论文信息 - Anti-HER2 CD4+ T-helper type 1 response is a novel immune correlate to pathologic response following neoadjuvant therapy in HER2-positive breast cancer - 字舞流文

Anti-HER2 CD4+ T-helper type 1 response is a novel immune correlate to pathologic response following neoadjuvant therapy in HER2-positive breast cancer

B. Czerniecki | A. DeMichele | Shuwen Xu | Paul J. L. Zhang | R. Roses | N. Goodman | E. Berk | C. Fisher | J. Datta | E. Fitzpatrick | Cinthia Rosemblit | D. Lewis | L. Lowenfeld | C. Rosemblit